Education
About Us
Working with TipRanks
Follow Us
MedCap AB (SE:MCAP)
:MCAP
Total Valuation
MedCap AB has a market cap or net worth of kr7.24B. The enterprise value is kr7.55B.
Market Capkr7.24B
Enterprise Valuekr7.55B
Share Statistics
MedCap AB has 15,077,583 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,077,583
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedCap AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.04%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)10.04%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee3.70M
Profits Per Employee531.40K
Employee Count570
Asset Turnover0.81
Inventory Turnover6.69
Valuation Ratios
The current PE Ratio of MedCap AB is 32.7. MedCap AB’s PEG ratio is 7.70.
PE Ratio32.7
PS Ratio3.90
PB Ratio5.67
Price to Fair Value5.67
Price to FCF29.33
Price to Operating Cash Flow20.88
PEG Ratio7.70
Income Statement
In the last 12 months, MedCap AB had revenue of 2.11B and earned 219.80M in profits. Earnings per share was 14.67.
Revenue2.11B
Gross Profit291.20M
Operating Income291.20M
Pretax Income289.00M
Net Income219.80M
EBITDA473.90M
Earnings Per Share (EPS)14.67
Cash Flow
In the last 12 months, operating cash flow was 342.60M and capital expenditures -54.10M, giving a free cash flow of 288.50M billion.
Operating Cash Flow342.60M
Free Cash Flow288.50M
Free Cash Flow per Share19.13
Dividends & Yields
MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change16.08%
50-Day Moving Average524.00
200-Day Moving Average538.83
Relative Strength Index (RSI)40.94
Average Volume (3m)21.82K
Important Dates
MedCap AB upcoming earnings date is Apr 29, 2026, TBA (Confirmed).
Last Earnings DateFeb 6, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
MedCap AB as a current ratio of 2.01, with Debt / Equity ratio of 48.69%
Current Ratio2.01
Quick Ratio1.46
Debt to Market Cap0.05
Net Debt to EBITDA0.71
Interest Coverage Ratio9.24
Taxes
In the past 12 months, MedCap AB has paid 68.30M in taxes.
Income Tax68.30M
Effective Tax Rate0.24
Enterprise Valuation
MedCap AB EV to EBITDA ratio is 18.07, with an EV/FCF ratio of 30.53.
EV to Sales4.06
EV to EBITDA18.07
EV to Free Cash Flow30.53
EV to Operating Cash Flow24.99
Balance Sheet
MedCap AB has kr370.40M in cash and marketable securities with kr707.00M in debt, giving a net cash position of -kr336.60M billion.
Cash & Marketable Securitieskr370.40M
Total Debtkr707.00M
Net Cash-kr336.60M
Net Cash Per Share-kr22.32
Tangible Book Value Per Sharekr15.34
Margins
Gross margin is 48.39%, with operating margin of 13.81%, and net profit margin of 10.43%.
Gross Margin48.39%
Operating Margin13.81%
Pretax Margin13.71%
Net Profit Margin10.43%
EBITDA Margin22.48%
EBIT Margin15.20%
Analyst Forecast
The average price target for MedCap AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.30%
EPS Growth Forecast-14.49%